Sustainable Blocking Solutions for Immunoassay Manufacturing - Recombinant Mouse IgG

Terri Borree has over 30 years of experience in the industry. She began her career at George Washington University facilitating the use of cutting-edge flow cytometry technology in clinical hospital testing for CD4 counts and Leukemia/Lymphoma diagnostic panels. She expanded that experience to support clinical research immunoassay projects at Walter Reed Army Medical Center. Those experiences led Terri to work for companies including Beckman Coulter, Affymetrix, and now Merck in various technical roles. She currently works as the Portfolio Manager for select Diagnostic Immunoassay Critical Raw Material Reagents including antibodies, blocking agents, and biocides.